Tag Archive | "Amgen"

Amgen and MD Anderson in bispecific T cell engager (BiTE) antibody pact

Tags: , ,


Amgen and The University of Texas MD Anderson Cancer Center announced a research collaborative agreement focusing on Amgen's bispecific T cell engager (BiTE) antibody constructs Read the full story

Amgen and Kite Pharma collaborate in CAR T cell immunotherapies

Tags: , ,


Amgen and Kite Pharma have entered into a strategic research collaboration and license agreement to develop and commercialize the next generation of novel Chimeric Antigen Receptor (CAR) T cell immunotherapies Read the full story

Amgen biopharma partners for supporting startups

Tags: , ,


Amgen and LabCentral biopharma partners: announced an agreement in which Amgen has become a LabCentral platinum sponsor. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Onyx Pharmaceuticals: Oncology specialists and a subsidiary of Amgen

Tags: , , ,


Onyx Pharmaceuticals is a biotechnology company based in San Francisco developing therapies for the treatment of people living with cancer. Read the full story

Amgen

Tags: ,


Amgen is a top biotechnology company based in Thousand Oaks, CA, USA Read the full story

Merck forms pharma partnering with Amgen, Pfizer and Incyte

Tags: , , , ,


Merck  has signed three separate pharma partnering clinical collaboration agreements, through subsidiaries, with Amgen Inc., Incyte Corporation and Pfizer Inc. to evaluate novel combination regimens with MK-3475, Merck’s investigational anti-PD-1 immunotherapy. Read the full story

Pharma deal between Illumina and Amgen

Tags: , ,


Illumina has entered into an pharma deal agreement with Amgen to develop and commercialize a multigene, NGS-based test as a companion diagnostic for Vectibix (panitumumab). Read the full story

Amgen signs a pharma licensing agreement with Carmot

Tags: , ,


Carmot Therapeutics has entered into a collaboration and pharma license agreement with Amgen. Read the full story

Amgen biopharma partners with Roche for neutropenia drugs

Tags: , , ,


Amgen biopharma partners by acquiring Roche's rights to the neutropenia drugs filgrastim and pegfilgrastim, effective January 1, 2014 Read the full story